This post is from a suggested group
Montelukast API Market Overview: Growth Driven by Rising Respiratory Disorders
The Montelukast API Market is experiencing notable growth, primarily fueled by the increasing prevalence of asthma, allergic rhinitis, and other respiratory disorders worldwide. Montelukast, a leukotriene receptor antagonist (LTRA), is widely used for preventing and managing chronic asthma and relieving symptoms of seasonal allergies.
The growing demand for effective and affordable respiratory medications has strengthened the global production and distribution network of Montelukast active pharmaceutical ingredients (APIs).
Market Overview and Dynamics
The global market for Montelukast API is driven by the rising incidence of respiratory illnesses due to pollution, smoking, and urban lifestyle changes. The drug’s safety profile and effectiveness make it a preferred choice among physicians. Additionally, the availability of Montelukast in multiple formulations—tablets, chewable tablets, and granules—enhances its accessibility across patient demographics, including pediatric populations.
Pharmaceutical manufacturers are investing in large-scale API synthesis, leveraging advanced chemical engineering techniques to improve yield and purity. The increasing adoption of generic formulations…
Great job